<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04247009</url>
  </required_header>
  <id_info>
    <org_study_id>PIRA</org_study_id>
    <nct_id>NCT04247009</nct_id>
  </id_info>
  <brief_title>Postprandial Inflammation in Rheumatoid Arthritis</brief_title>
  <acronym>PIRA</acronym>
  <official_title>Postprandial Inflammation in Rheumatoid Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Göteborg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with RA will be studied to see whether meals of different content will affect&#xD;
      inflammation and metabolic variables in the postprandial state. Healthy controls will also be&#xD;
      invited to examine potentially different responses to patients with RA.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The PIRA study aims to evaluate the metabolic and inflammatory effects after a vegan meal or&#xD;
      a meal containing red meat or fish in patients with RA and matched controls. The study have a&#xD;
      cross-over design and each participant will have one of three meals every week and then be&#xD;
      compared to themselves. In addition healthy individuals will be included for the red meat&#xD;
      meal so that the response from this meal could be compared between patients with RA and their&#xD;
      matched controls. Blood samples will be collected before the meal (fasting) and every hour&#xD;
      until 5h. Primary outcome will be high sensitive IL-6. Secondary outcomes will be additional&#xD;
      inflammation markers such as area under curve for hs-CRP and gene expression in PBMC:s&#xD;
      regarding genes related to inflammation and, glucose, blood lipids and metabolomics-profile&#xD;
      in serum and urine.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>All data will be given a new code Before statistical analysis to mask treatment (study meal or Control) to the outcome assessor</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Circulating interleukin 6</measure>
    <time_frame>From baseline up to 5 hours postprandial</time_frame>
    <description>Changes from fasting to postprandial</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Circulating high sensitive C-reactive protein (CRP)</measure>
    <time_frame>From baseline up to 5 hours postprandial</time_frame>
    <description>Changes from fasting to 5 hours postprandial, area under curve</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Circulating triacylglycerides</measure>
    <time_frame>From baseline up to 5 hours postprandial</time_frame>
    <description>Blood lipid levels, Area Under curve from fasting to 5 hours postprandial</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gene expression analysis</measure>
    <time_frame>From baseline up to 5 hours postprandial</time_frame>
    <description>Changes in gene expressions related to inflammation and disease activity in peripheral blood mononuclear cells</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum metabolomics</measure>
    <time_frame>From baseline up to 5 hours postprandial</time_frame>
    <description>Patterns of nuclear magnetic resonance (NMR) analysis of metabolites, analysis of several timepoints separately</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Urine metabolomics</measure>
    <time_frame>From baseline up to 5 hours postprandial</time_frame>
    <description>Patterns of nuclear magnetic resonance (NMR) analysis of metabolites,analysis of several timepoints separately</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>Measured at inclusion of trial, expected to be complete within 6 months</time_frame>
    <description>Measured by dual energy X-ray technology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>Measured at inclusion and during trial, expected to be complete within 1 year</time_frame>
    <description>measured by electric impedance analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting metabolic rate</measure>
    <time_frame>through study completion, expected within 1 year</time_frame>
    <description>measured by indirect calorimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose</measure>
    <time_frame>From baseline up to 5 hours postprandial</time_frame>
    <description>blood glucose levels measured by NMR-analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>From baseline up to 5 hours postprandial</time_frame>
    <description>blood insulin levels measured by NMR-analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported quality of life</measure>
    <time_frame>through study completion, expected to be complete within 1 year</time_frame>
    <description>Measured by EQ5D-5L questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported health</measure>
    <time_frame>through study completion, expected to be complete within 1 year</time_frame>
    <description>Measured by the Short Form (SF36) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported dietary intake</measure>
    <time_frame>Through study completion, expected to be complete within 1 year</time_frame>
    <description>measured by food frequency questionnaire and 4-day food diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported background and dietary habits</measure>
    <time_frame>During trial, expected to be complete within 1 year</time_frame>
    <description>Measured by questionnaire about socioeconomic status and changes in dietary habits related to perceived health</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported disability</measure>
    <time_frame>During trial, expected to be complete within 1 year</time_frame>
    <description>Health Assessment Questionnaire, disability index (HAQ)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Arthritis, Rheumatoid</condition>
  <condition>Inflammatory Response</condition>
  <condition>Dietary Exposure</condition>
  <condition>Diet, Healthy</condition>
  <arm_group>
    <arm_group_label>Meat</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with RA served a meal of meat</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fish</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with RA served a meal of fish</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vegan</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with RA served a vegan meal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Meat controls</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Matched controls served a meal of meat</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Meal based on red meat, fish products or vegan products</intervention_name>
    <description>Three meals will be served</description>
    <arm_group_label>Fish</arm_group_label>
    <arm_group_label>Meat</arm_group_label>
    <arm_group_label>Vegan</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Meal based on red meat</intervention_name>
    <description>Matched Controls will be served only one meal of meat to compare response between (non-RA) matched controls and patients with RA</description>
    <arm_group_label>Meat</arm_group_label>
    <arm_group_label>Meat controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for patients with RA:&#xD;
&#xD;
          -  Diagnosed with rheumatoid arthritis&#xD;
&#xD;
          -  BMI 18.5-30.0 kg/m2&#xD;
&#xD;
          -  2 years or more since diagnosis&#xD;
&#xD;
          -  No DMARD changes during the last 3 months&#xD;
&#xD;
        Inclusion Criteria for healthy controls:&#xD;
&#xD;
          -  Absence of diagnosis of RA&#xD;
&#xD;
          -  BMI 18.5-30.0 kg/m2&#xD;
&#xD;
          -  Self-assessed as healthy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of cancer, inflammatory bowel disease, celiac disease, diabetes&#xD;
&#xD;
          -  Allergy or intolerance to any of the foods in the study&#xD;
&#xD;
          -  Pregnancy or breastfeeding&#xD;
&#xD;
          -  Use of any blood lipid lowering medication, glucocorticoids or IL-6-inhibitor during&#xD;
             the last 4 weeks prior to enrolment&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Hemoglobin &lt; 100 g/L&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helen HL Lindqvist, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Göteborg University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erik EH Hulander, MSc, RD</last_name>
    <phone>+46 (31) 7863725</phone>
    <email>erik.hulander@gu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Helen HL Lindqvist, PhD</last_name>
    <phone>+46 (31) 7863723</phone>
    <email>helen.lindqvist@gu.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Göteborg</city>
        <state>Not In US/Canada</state>
        <zip>405 30</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helen M Lindqvist, PhD</last_name>
      <phone>+46317863723</phone>
      <email>helen.lindqvist@gu.se</email>
    </contact>
    <contact_backup>
      <last_name>Inger Gjertsson, PhD, MD</last_name>
      <phone>+460730246725</phone>
      <email>inger.gjertsson@rheuma.gu.se</email>
    </contact_backup>
    <investigator>
      <last_name>Linnea LB Bärebring, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erik EH Hulander, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 21, 2020</study_first_submitted>
  <study_first_submitted_qc>January 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2020</study_first_posted>
  <last_update_submitted>September 24, 2021</last_update_submitted>
  <last_update_submitted_qc>September 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>postprandial</keyword>
  <keyword>inflammation</keyword>
  <keyword>rheumatoid arthritis</keyword>
  <keyword>RA</keyword>
  <keyword>diet</keyword>
  <keyword>PIRA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data cannot be shared publicly because of Swedish law. The datasets analysed could be made available from the corresponding author on reasonable request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

